WTB
SGMO

Washington Trust Bank’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Washington Trust Bank’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-3,000
Closed -$17K – 1172
2016
Q2 		$17K Buy
+3,000
New +$19.1K ﹤0.01% 508

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Washington Trust Bank's SGMO Position: Q3 2016 in Review

Washington Trust Bank sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2016, closing a stake of 3,000 shares — an estimated $17K sold.

Washington Trust Bank first reported a position in SGMO in Q2 2016 and held it in 1 quarter. The position peaked at $17K in Q2 2016. 124 funds tracked by Wall St. Rank hold SGMO as of Q3 2016.

  • Washington Trust Bank reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2016 after selling out during the quarter.
  • Washington Trust Bank sold 3,000 SANGAMO THERAPEUTICS INC shares in Q3 2016, an estimated $17K.
  • Washington Trust Bank first reported a position in SANGAMO THERAPEUTICS INC in Q2 2016 and held it in 1 quarter.
  • Washington Trust Bank's SANGAMO THERAPEUTICS INC position peaked at $17K in Q2 2016.
  • 124 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2016.

Based on Washington Trust Bank's 13F filing for Q3 2016, filed 4 Oct 2016.